kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports KRAS G12V mutation-selective requirement for
KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy PMC Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



